2022
DOI: 10.17219/acem/146273
|View full text |Cite
|
Sign up to set email alerts
|

Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis

Abstract: Bradley SA, Smokovski I, Bhaskar SMM. Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis [published online as ahead of print on February 25, 2022].

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 53 publications
(65 reference statements)
0
4
0
Order By: Relevance
“…32 Our male infarct size data support the above finding and are consistent with repeated clinical studies which indicate diabetes history and hyperglycemia are associated with increased infarct size and poorer functional outcome after pharmacological thrombolysis, mechanical or expectant therapy. 2,3,33,34 DM2 is a systemic disease which affects the brain parenchyma as well as its vasculature in ways that…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…32 Our male infarct size data support the above finding and are consistent with repeated clinical studies which indicate diabetes history and hyperglycemia are associated with increased infarct size and poorer functional outcome after pharmacological thrombolysis, mechanical or expectant therapy. 2,3,33,34 DM2 is a systemic disease which affects the brain parenchyma as well as its vasculature in ways that…”
Section: Discussionmentioning
confidence: 99%
“…2 Clinical trials indicate that DM2 increases the risk of poor functional outcome at discharge and 90 days after stroke in the patients receiving intravenous tPA (tissue-type plasminogen activator) or endovascular treatment. 3 DM2 and acute hyperglycemia are also associated with lower intravenous tPA–induced recanalization rate. 4,5 The exact mechanism by which DM2 and hyperglycemia exacerbate postreperfusion ischemic injury, while multifactorial and still being elucidated, appears to involve at least in part the compromised cerebral microvascular structure and function including endothelial dysfunction, thickened capillary basement membrane, and increased angiogenesis, increased blood-brain barrier permeability, and reduced cerebral vasoreactivity.…”
mentioning
confidence: 96%
“…Our study revealed that diabetes mellitus is another factor that is associated with futile recanalization. A meta-analysis has demonstrated that diabetes mellitus is linked to unfavorable functional outcomes, increased mortality, and poor postprocedural safety outcomes, including symptomatic intracranial hemorrhage (sICH) and hypertension (HT) ( 14 ). Genceviciute also discovered that diabetes mellitus, especially admission hyperglycemia, was associated with less frequently successful reperfusion, worse 3-month functional outcomes, and in-hospital symptomatic intracranial hemorrhage in acute anterior circulation stroke patients who underwent EVT ( 15 , 16 ).…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes mellitus type 2 (DMT2) patients are several times more susceptible to a stroke event due to various cerebrovascular complications [ 92 ]. Micro- and macro-vascular changes characteristic for DM lead to particularly poor IS outcomes, increased mortality, and poor post-procedural quality of life [ 93 , 94 ]. Moreover, glucose-lowering therapies are insufficient protection against IS risks in DM [ 95 , 96 ].…”
Section: Ongoing 3pm Research Towards Vulnerable Groups In the Popula...mentioning
confidence: 99%